By combining next generation computing power with the clinical expertise of a certified CAP/CLIA lab, Breakthrough Genomics tests deliver high diagnostic yields with fast turnaround times.
Breakthrough Genomics works with healthcare providers, research institutions, and partner organizations to provide genetic tests both in the U.S. and around the world.
Breakthrough Genomics offers a wide range of advanced genetic tests from hereditary cancer and cardiovascular screening to rare disease diagnosis and rapid Whole Genome and Whole Exome tests for the NICU and PICU.
The company provides specialized service to advance clinical trials and companion diagnostics, including advanced genomic interpretation capabilities, assay development, and a number of tests for early cancer detection and MRD (minimal residual disease) Monitoring.
Breakthrough Genomics leverages the company’s proprietary technology and hands-on experience in clinical genomics to help solve the biggest challenges
in precision medicine.